Researchers randomly studied two Mendelian samples to determine whether there was a correlation between the genetically reduced vascular endothelial growth factor (VEGF) and the reduced BMD and the increased fracture risk. In total, 76,549 cases and 470,164 were selected for this meta-analysis. They have implemented summary statistics from meta-analysis of studies on a conglomerate association to spread the level of VEGF to diagnose 10 genetic variants explaining up to 52% of the variance in spreading VEGF levels. The results indicated that no combination of VEGF genetically dispersed with BMD reduction or increased risk of fracture, indicating that results are unlikely to have beneficial effects in spreading VEGF on osteoporosis results and that causation or limitation was affected by causation. change.
Read the full article on the Journal of Bone and Mineral Research
(TTTranslate) Medical article (t) BIOCIDAL MARKERS TRAINING ON BASIS (t) LAND PROTECTION (t) GENERAL POPULATION STUDY (t) HUMAN CAPACITY STUDY (t) OSTEOPOROSIS Endocrinology news section